ArticlePLoS computational biology2021

Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs.

Tomás Alarcón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.